S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
66,000% upside on tiny biotech? (Ad)
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:NEPH

Nephros (NEPH) Stock Forecast, Price & News

$1.79
-0.23 (-11.39%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.77
▼
$1.94
50-Day Range
$1.04
▼
$2.02
52-Week Range
$0.91
▼
$2.50
Volume
83,809 shs
Average Volume
215,583 shs
Market Capitalization
$18.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

NEPH stock logo

About Nephros (NASDAQ:NEPH) Stock

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

NEPH Stock News Headlines

June 2, 2023 | msn.com
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
May 30, 2023 | americanbankingnews.com
Nephros, Inc. (NASDAQ:NEPH) Short Interest Down 13.8% in May
June 4, 2023 | Stocks To Trade (Ad)
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
May 24, 2023 | finance.yahoo.com
Nephros to Present at LD Micro Invitational XIII
May 13, 2023 | markets.businessinsider.com
Sientra (SIEN) Gets a Buy from Maxim Group
May 12, 2023 | msn.com
Nephros GAAP EPS of -$0.03 misses by $0.01, revenue of $3.7M beats by $0.02M
May 10, 2023 | finance.yahoo.com
Nephros Announces Results for Quarter Ended March 31, 2023
May 9, 2023 | americanbankingnews.com
Nephros (NEPH) Set to Announce Quarterly Earnings on Wednesday
June 4, 2023 | Stocks To Trade (Ad)
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
May 8, 2023 | finanznachrichten.de
Nephros, Inc.: Nephros Announces CEO Retirement and Succession Plan
May 8, 2023 | finance.yahoo.com
Nephros Announces CEO Retirement and Succession Plan
May 3, 2023 | americanbankingnews.com
Head-To-Head Analysis: Nephros (NASDAQ:NEPH) and KORU Medical Systems (NASDAQ:KRMD)
April 26, 2023 | finance.yahoo.com
Nephros Schedules First Quarter 2023 Financial Results Conference Call
April 24, 2023 | marketwatch.com
Dialysis WaterFiltration Market 2023 by Sales, Share, Growth Opportunity with Top Players are Nephros, Evoqua,Culligan, Veolia Water Technologies
April 6, 2023 | benzinga.com
Nephros, Inc. (NEPH) Stock Rises 22.86% This Week; Should You Buy?
April 6, 2023 | markets.businessinsider.com
Nephros (NEPH) Receives a Buy from Maxim Group
April 4, 2023 | msn.com
Nephros Soars after Better-than-Expected Preliminary Q1 Revenues
April 4, 2023 | finanznachrichten.de
Nephros, Inc.: Nephros Announces Preliminary Results for First Quarter 2023
April 4, 2023 | finance.yahoo.com
Nephros Announces Preliminary Results for First Quarter 2023
April 1, 2023 | americanbankingnews.com
Contrasting Nephros (NASDAQ:NEPH) and Treace Medical Concepts (NASDAQ:TMCI)
March 11, 2023 | finance.yahoo.com
Nephros, Inc. (NASDAQ:NEPH) Q4 2022 Earnings Call Transcript
March 10, 2023 | finance.yahoo.com
Nephros Full Year 2022 Earnings: Misses Expectations
March 9, 2023 | finance.yahoo.com
Q4 2022 Nephros Inc Earnings Call
March 9, 2023 | finanznachrichten.de
Nephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
March 8, 2023 | finance.yahoo.com
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
March 7, 2023 | msn.com
Nephros's Earnings: A Preview
March 2, 2023 | msn.com
Nephros and Donastar enter new strategic partnership
See More Headlines

NEPH Price History

NEPH Company Calendar

Last Earnings
5/10/2023
Today
6/04/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NEPH
CUSIP
N/A
CIK
1196298
Web
www.nephros.com
Phone
(201) 343-5202
Fax
201-343-5207
Employees
34
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,380,000.00
Net Margins
-47.90%
Pretax Margin
-26.25%
Return on Equity
-30.34%
Return on Assets
-25.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.88
Quick Ratio
4.22

Sales & Book Value

Annual Sales
$9.98 million
Price / Sales
1.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.85 per share
Price / Book
2.11

Miscellaneous

Outstanding Shares
10,480,000
Free Float
9,950,000
Market Cap
$18.76 million
Optionable
Not Optionable
Beta
1.24

Key Executives

  • Robert Banks
    President, Chief Executive Officer & Director
  • Andrew AstorAndrew Astor
    Chief Financial Officer
  • Michael Milman
    Vice President-Research & Development
  • Anthony Robinson
    Vice President-Operations
  • Alfred Vargas
    Director-Logistics & Manufacturing

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













NEPH Stock - Frequently Asked Questions

How have NEPH shares performed in 2023?

Nephros' stock was trading at $1.1572 on January 1st, 2023. Since then, NEPH stock has increased by 54.7% and is now trading at $1.79.
View the best growth stocks for 2023 here.

Are investors shorting Nephros?

Nephros saw a decrease in short interest in May. As of May 15th, there was short interest totaling 18,100 shares, a decrease of 13.8% from the April 30th total of 21,000 shares. Based on an average daily volume of 16,700 shares, the short-interest ratio is presently 1.1 days. Approximately 0.2% of the company's shares are sold short.
View Nephros' Short Interest.

When is Nephros' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our NEPH earnings forecast.

How were Nephros' earnings last quarter?

Nephros, Inc. (NASDAQ:NEPH) issued its earnings results on Wednesday, May, 10th. The company reported ($0.03) EPS for the quarter. The business had revenue of $3.70 million for the quarter. Nephros had a negative trailing twelve-month return on equity of 30.34% and a negative net margin of 47.90%.

What guidance has Nephros issued on next quarter's earnings?

Nephros issued an update on its first quarter 2023 earnings guidance on Tuesday, April, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.70 million-$3.70 million, compared to the consensus revenue estimate of $2.68 million.

What is Nephros' stock symbol?

Nephros trades on the NASDAQ under the ticker symbol "NEPH."

Who are Nephros' major shareholders?

Nephros' stock is owned by many different retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.34%) and Renaissance Technologies LLC (0.22%). Insiders that own company stock include Andrew Astor, Tom Gwydir and Wesley S Lobo.
View institutional ownership trends.

How do I buy shares of Nephros?

Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nephros' stock price today?

One share of NEPH stock can currently be purchased for approximately $1.79.

How much money does Nephros make?

Nephros (NASDAQ:NEPH) has a market capitalization of $18.76 million and generates $9.98 million in revenue each year.

How can I contact Nephros?

Nephros' mailing address is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. The official website for the company is www.nephros.com. The company can be reached via phone at (201) 343-5202, via email at ksmith@pcgadvisory.com, or via fax at 201-343-5207.

This page (NASDAQ:NEPH) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -